New User? Sign Up | Sign In

Insider Trading - PARMAR KUSH

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for PARMAR KUSH

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-11-16
Sale
2018-11-20
5:05 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
525,900 $20.2 $10,623,180 247,845
(Indirect)
View
2018-11-23
Sale
2018-11-27
6:09 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
29,682 $20.04 $594,709 246,658
(Indirect)
View
2018-12-10
Sale
2018-12-12
8:10 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
15,575 $26.01 $405,029 246,035
(Indirect)
View
2019-05-16
Sale
2019-05-20
4:24 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
615,000 $21.47 $13,204,050 221,435
(Indirect)
View
2019-10-07
Purchase
2019-10-09
6:23 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
333,333 $15 $4,999,995 333,333
(Indirect)
View
2019-10-29
Purchase
2019-10-31
6:03 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
454,545 $11 $4,999,995 454,545
(Indirect)
View
2020-05-19
Sale
2020-05-21
9:31 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
255,000 $35.15 $8,963,250 90,572
(Indirect)
View
2020-06-11
Sale
2020-06-15
9:12 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
245,000 $28.75 $7,044,412 80,772
(Indirect)
View
2020-06-16
Sale
2020-06-18
7:22 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
140,000 $33.3 $4,662,000 313,497
(Indirect)
View
2020-06-30
Purchase
2020-07-02
4:17 pm
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
294,117 $17 $4,999,989 1,094,101
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-08-24
Option Award
2016-08-25
9:52 pm
N/A
2026-08-24
Audentes Therapeutics Inc. BOLD PARMAR KUSH
Director
18,000 $15.03 18,000
(Direct)
View
2017-10-08
Option Award
2017-10-10
6:05 pm
N/A
2027-10-08
Audentes Therapeutics Inc. BOLD PARMAR KUSH
Director
9,000 $26.01 9,000
(Direct)
View
2018-03-27
Option Award
2018-03-29
7:27 pm
N/A
2028-03-27
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
31,160 $16 31,160
(Direct)
View
2018-04-02
Conversion
2018-04-04
4:24 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
5,392,037 $0 0
(Indirect)
View
2018-04-02
Conversion
2018-04-04
4:24 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
4,204,502 $0 0
(Indirect)
View
2018-04-02
Conversion
2018-04-04
4:24 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
1,187,535 $0 0
(Indirect)
View
2018-04-02
Conversion
2018-04-04
7:09 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
5,392,037 $0 6,722,076
(Indirect)
View
2018-06-08
Option Award
2018-06-08
5:23 pm
N/A
2028-06-08
Audentes Therapeutics Inc. BOLD PARMAR KUSH
Director
10,000 $38.65 10,000
(Direct)
View
2018-06-19
Option Award
2018-06-21
6:39 pm
2019-06-19
2028-06-19
scPharmaceuticals Inc. SCPH PARMAR KUSH
Director
6,124 $5.53 6,124
(Direct)
View
2019-05-23
Option Award
2019-05-28
5:08 pm
N/A
2029-05-22
ARVINAS Inc ARVN PARMAR KUSH
Director
12,923 $22.06 12,923
(Direct)
View
2019-06-06
Option Award
2019-06-10
5:09 pm
N/A
2029-06-06
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
15,580 $19.51 15,580
(Direct)
View
2019-09-16
Other
2019-09-18
9:33 pm
N/A
N/A
ARVINAS Inc ARVN PARMAR KUSH
Director
3,475 $0 3,475
(Direct)
View
2019-09-24
Gift
2019-09-26
6:54 pm
N/A
N/A
ARVINAS Inc ARVN PARMAR KUSH
Director
1,700 $0 1,775
(Direct)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
1,913,910 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
79,746 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
492,475 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
20,519 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
1,913,910 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
79,746 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
492,475 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
20,519 $0 333,333
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:03 pm
N/A
N/A
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
3,214,721 $0 454,545
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:03 pm
N/A
N/A
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
3,146,551 $0 454,545
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:03 pm
N/A
N/A
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
1,675,532 $0 454,545
(Indirect)
View
2020-06-10
Option Award
2020-06-12
5:31 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
18,000 $16.32 18,000
(Direct)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
513,757 $0 1,094,101
(Indirect)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
1,997,946 $0 1,094,101
(Indirect)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
999,980 $0 1,094,101
(Indirect)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
799,984 $0 1,094,101
(Indirect)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
10,826,417 $0 1,094,101
(Indirect)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
42,102,728 $0 1,094,101
(Indirect)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
21,072,596 $0 1,094,101
(Indirect)
View
2020-06-30
Conversion
2020-07-02
4:17 pm
N/A
N/A
Akouos Inc. AKUS PARMAR KUSH
Director
10% Owner
16,858,076 $0 1,094,101
(Indirect)
View